Selected research
Industry Research
Metronidazole Tablet Industry Research Report 2026
Market perspective
The global Metronidazole Tablet market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Metronidazole Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Metronidazole Tablet is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Metronidazole Tablet is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Metronidazole Tablet include Yichang Changjiang Pharmaceutical, Wuyao Pharmaceutical, Zhongan Pharmaceutical, Tongji Pharmaceutical, Yinhe Aarti Pharmaceutical, Saikang Pharmaceutical, Hongda Pharmaceutical, Hongyuan Pharmaceutical and Unichem Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Metronidazole Tablet market in terms of revenue (US$ million) and, where applicable, sales volume (K Pcs), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Pcs) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Metronidazole Tablet Market by Company
Yichang Changjiang Pharmaceutical
Wuyao Pharmaceutical
Zhongan Pharmaceutical
Tongji Pharmaceutical
Yinhe Aarti Pharmaceutical
Saikang Pharmaceutical
Hongda Pharmaceutical
Hongyuan Pharmaceutical
Unichem Laboratories
Topsun Pharmaceutical
Manav Drugs
CordenPharma Farchemia
API Polpharma
Aarti Drugs
Aarey Drugs & Pharmaceuticals
Metronidazole Tablet Segment by Type
Glyoxal Process
Ethidene Diamine Process
Others
Metronidazole Tablet Segment by Application
Hospital
Clinic
Other
Metronidazole Tablet Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metronidazole Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Metronidazole Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metronidazole Tablet.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Metronidazole Tablet manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Metronidazole Tablet by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Metronidazole Tablet in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Glyoxal Process
- Ethidene Diamine Process
- Others
Applications
- Hospital
- Clinic
- Other
Companies covered
- Yichang Changjiang Pharmaceutical
- Wuyao Pharmaceutical
- Zhongan Pharmaceutical
- Tongji Pharmaceutical
- Yinhe Aarti Pharmaceutical
- Saikang Pharmaceutical
- Hongda Pharmaceutical
- Hongyuan Pharmaceutical
- Unichem Laboratories
- Topsun Pharmaceutical
- Manav Drugs
- CordenPharma Farchemia
- API Polpharma
- Aarti Drugs
- Aarey Drugs & Pharmaceuticals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Metronidazole Tablet Market Size (2021-2032)
- 2.2.2 Global Metronidazole Tablet Sales (2021-2032)
- 2.2.3 Global Metronidazole Tablet Market Average Price (2021-2032)
- 2.3 Metronidazole Tablet by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Glyoxal Process
- 2.3.3 Ethidene Diamine Process
- 2.3.4 Others
- 2.4 Metronidazole Tablet by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Metronidazole Tablet Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Metronidazole Tablet Sales (K Pcs) of Manufacturers (2021-2026)
- 3.3 Global Metronidazole Tablet Revenue of Manufacturers (2021-2026)
- 3.4 Global Metronidazole Tablet Average Price by Manufacturers (2021-2026)
- 3.5 Global Metronidazole Tablet Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Metronidazole Tablet, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Metronidazole Tablet, Product Type & Application
- 3.8 Global Manufacturers of Metronidazole Tablet, Established Date
- 3.9 Global Metronidazole Tablet Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Yichang Changjiang Pharmaceutical
- 4.1.1 Yichang Changjiang Pharmaceutical Company Information
- 4.1.2 Yichang Changjiang Pharmaceutical Business Overview
- 4.1.3 Yichang Changjiang Pharmaceutical Metronidazole Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Yichang Changjiang Pharmaceutical Metronidazole Tablet Product Portfolio
- 4.1.5 Yichang Changjiang Pharmaceutical Recent Developments
- 4.2 Wuyao Pharmaceutical
- 4.2.1 Wuyao Pharmaceutical Company Information
- 4.2.2 Wuyao Pharmaceutical Business Overview
- 4.2.3 Wuyao Pharmaceutical Metronidazole Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Wuyao Pharmaceutical Metronidazole Tablet Product Portfolio
- 4.2.5 Wuyao Pharmaceutical Recent Developments
- 4.3 Zhongan Pharmaceutical
- 4.3.1 Zhongan Pharmaceutical Company Information
- 4.3.2 Zhongan Pharmaceutical Business Overview
- 4.3.3 Zhongan Pharmaceutical Metronidazole Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Zhongan Pharmaceutical Metronidazole Tablet Product Portfolio
- 4.3.5 Zhongan Pharmaceutical Recent Developments
- 4.4 Tongji Pharmaceutical
- 4.4.1 Tongji Pharmaceutical Company Information
- 4.4.2 Tongji Pharmaceutical Business Overview
- 4.4.3 Tongji Pharmaceutical Metronidazole Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Tongji Pharmaceutical Metronidazole Tablet Product Portfolio
- 4.4.5 Tongji Pharmaceutical Recent Developments
- 4.5 Yinhe Aarti Pharmaceutical
- 4.5.1 Yinhe Aarti Pharmaceutical Company Information
- 4.5.2 Yinhe Aarti Pharmaceutical Business Overview
- 4.5.3 Yinhe Aarti Pharmaceutical Metronidazole Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Yinhe Aarti Pharmaceutical Metronidazole Tablet Product Portfolio
- 4.5.5 Yinhe Aarti Pharmaceutical Recent Developments
- 4.6 Saikang Pharmaceutical
- 4.6.1 Saikang Pharmaceutical Company Information
- 4.6.2 Saikang Pharmaceutical Business Overview
- 4.6.3 Saikang Pharmaceutical Metronidazole Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Saikang Pharmaceutical Metronidazole Tablet Product Portfolio
- 4.6.5 Saikang Pharmaceutical Recent Developments
- 4.7 Hongda Pharmaceutical
- 4.7.1 Hongda Pharmaceutical Company Information
- 4.7.2 Hongda Pharmaceutical Business Overview
- 4.7.3 Hongda Pharmaceutical Metronidazole Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Hongda Pharmaceutical Metronidazole Tablet Product Portfolio
- 4.7.5 Hongda Pharmaceutical Recent Developments
- 4.8 Hongyuan Pharmaceutical
- 4.8.1 Hongyuan Pharmaceutical Company Information
- 4.8.2 Hongyuan Pharmaceutical Business Overview
- 4.8.3 Hongyuan Pharmaceutical Metronidazole Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Hongyuan Pharmaceutical Metronidazole Tablet Product Portfolio
- 4.8.5 Hongyuan Pharmaceutical Recent Developments
- 4.9 Unichem Laboratories
- 4.9.1 Unichem Laboratories Company Information
- 4.9.2 Unichem Laboratories Business Overview
- 4.9.3 Unichem Laboratories Metronidazole Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Unichem Laboratories Metronidazole Tablet Product Portfolio
- 4.9.5 Unichem Laboratories Recent Developments
- 4.10 Topsun Pharmaceutical
- 4.10.1 Topsun Pharmaceutical Company Information
- 4.10.2 Topsun Pharmaceutical Business Overview
- 4.10.3 Topsun Pharmaceutical Metronidazole Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Topsun Pharmaceutical Metronidazole Tablet Product Portfolio
- 4.10.5 Topsun Pharmaceutical Recent Developments
- 4.11 Manav Drugs
- 4.11.1 Manav Drugs Company Information
- 4.11.2 Manav Drugs Business Overview
- 4.11.3 Manav Drugs Metronidazole Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Manav Drugs Metronidazole Tablet Product Portfolio
- 4.11.5 Manav Drugs Recent Developments
- 4.12 CordenPharma Farchemia
- 4.12.1 CordenPharma Farchemia Company Information
- 4.12.2 CordenPharma Farchemia Business Overview
- 4.12.3 CordenPharma Farchemia Metronidazole Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 CordenPharma Farchemia Metronidazole Tablet Product Portfolio
- 4.12.5 CordenPharma Farchemia Recent Developments
- 4.13 API Polpharma
- 4.13.1 API Polpharma Company Information
- 4.13.2 API Polpharma Business Overview
- 4.13.3 API Polpharma Metronidazole Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 API Polpharma Metronidazole Tablet Product Portfolio
- 4.13.5 API Polpharma Recent Developments
- 4.14 Aarti Drugs
- 4.14.1 Aarti Drugs Company Information
- 4.14.2 Aarti Drugs Business Overview
- 4.14.3 Aarti Drugs Metronidazole Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Aarti Drugs Metronidazole Tablet Product Portfolio
- 4.14.5 Aarti Drugs Recent Developments
- 4.15 Aarey Drugs & Pharmaceuticals
- 4.15.1 Aarey Drugs & Pharmaceuticals Company Information
- 4.15.2 Aarey Drugs & Pharmaceuticals Business Overview
- 4.15.3 Aarey Drugs & Pharmaceuticals Metronidazole Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Aarey Drugs & Pharmaceuticals Metronidazole Tablet Product Portfolio
- 4.15.5 Aarey Drugs & Pharmaceuticals Recent Developments
5 Global Metronidazole Tablet Market Scenario by Region
- 5.1 Global Metronidazole Tablet Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Metronidazole Tablet Sales by Region: 2021-2032
- 5.2.1 Global Metronidazole Tablet Sales by Region: 2021-2026
- 5.2.2 Global Metronidazole Tablet Sales by Region: 2027-2032
- 5.3 Global Metronidazole Tablet Revenue by Region: 2021-2032
- 5.3.1 Global Metronidazole Tablet Revenue by Region: 2021-2026
- 5.3.2 Global Metronidazole Tablet Revenue by Region: 2027-2032
- 5.4 North America Metronidazole Tablet Market Facts & Figures by Country
- 5.4.1 North America Metronidazole Tablet Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Metronidazole Tablet Sales by Country (2021-2032)
- 5.4.3 North America Metronidazole Tablet Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Metronidazole Tablet Market Facts & Figures by Country
- 5.5.1 Europe Metronidazole Tablet Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Metronidazole Tablet Sales by Country (2021-2032)
- 5.5.3 Europe Metronidazole Tablet Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Metronidazole Tablet Market Facts & Figures by Country
- 5.6.1 Asia Pacific Metronidazole Tablet Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Metronidazole Tablet Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Metronidazole Tablet Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Metronidazole Tablet Market Facts & Figures by Country
- 5.7.1 South America Metronidazole Tablet Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Metronidazole Tablet Sales by Country (2021-2032)
- 5.7.3 South America Metronidazole Tablet Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Metronidazole Tablet Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Metronidazole Tablet Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Metronidazole Tablet Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Metronidazole Tablet Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Metronidazole Tablet Sales by Type (2021-2032)
- 6.1.1 Global Metronidazole Tablet Sales by Type (2021-2032) & (K Pcs)
- 6.1.2 Global Metronidazole Tablet Sales Market Share by Type (2021-2032)
- 6.2 Global Metronidazole Tablet Revenue by Type (2021-2032)
- 6.2.1 Global Metronidazole Tablet Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Metronidazole Tablet Revenue Market Share by Type (2021-2032)
- 6.3 Global Metronidazole Tablet Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Metronidazole Tablet Sales by Application (2021-2032)
- 7.1.1 Global Metronidazole Tablet Sales by Application (2021-2032) & (K Pcs)
- 7.1.2 Global Metronidazole Tablet Sales Market Share by Application (2021-2032)
- 7.2 Global Metronidazole Tablet Revenue by Application (2021-2032)
- 7.2.1 Global Metronidazole Tablet Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Metronidazole Tablet Revenue Market Share by Application (2021-2032)
- 7.3 Global Metronidazole Tablet Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Metronidazole Tablet Value Chain Analysis
- 8.1.1 Metronidazole Tablet Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Metronidazole Tablet Production Mode & Process
- 8.2 Metronidazole Tablet Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Metronidazole Tablet Distributors
- 8.2.3 Metronidazole Tablet Customers
9 Global Metronidazole Tablet Analyzing Market Dynamics
- 9.1 Metronidazole Tablet Industry Trends
- 9.2 Metronidazole Tablet Industry Drivers
- 9.3 Metronidazole Tablet Industry Opportunities and Challenges
- 9.4 Metronidazole Tablet Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst